Maravai Lifesciences Holdings (MRVI) Change in Account Payables (2020 - 2026)

Maravai Lifesciences Holdings' Change in Account Payables history runs 7 years deep, the most recent figure standing at $6.2 million for Q1 2026.

• In Q1 2026, Change in Account Payables rose 970.34% year-over-year to $6.2 million; the TTM figure through Mar 2026 stood at -$477000.0 (down 112.9% YoY), while the FY2025 annual figure was -$7.3 million, down 1116.18% from the prior year.
• Change in Account Payables was $6.2 million for Q1 2026 at Maravai Lifesciences Holdings, up from -$5.5 million in the prior quarter.
• In the past five years, Change in Account Payables ranged from a high of $6.2 million in Q1 2026 to a low of -$5.5 million in Q4 2025.
• Historically, Change in Account Payables has averaged $190823.5 across 5 years, with a median of $1.7 million in 2023.
• The sharpest annual moves came in 2024 and 2026: Change in Account Payables plunged 1466.81% in 2024, then soared 970.34% in 2026.
• A 5-year view of Change in Account Payables shows it stood at -$3.5 million in 2022, then soared by 147.84% to $1.7 million in 2023, then soared by 35.86% to $2.3 million in 2024, then plunged by 344.68% to -$5.5 million in 2025, then surged by 211.73% to $6.2 million in 2026.
• The last three Change in Account Payables figures came in at $6.2 million (Q1 2026), -$5.5 million (Q4 2025), and -$2.9 million (Q3 2025), per Business Quant data.